VERRICA PHARMACEUTICALS INC

Historical 13F Holders

Symbol
VRCA
CUSIP
92511W207
All holders as of
Q2 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 92511W207 since 12/18/2024, newest first.

Filer % of Class Filed
Armistice Capital, LLC 13G/A Amendment 4
4.99% 2/17/2026
Event 12/31/2025
Affinity Asset Advisors, LLC 13G/A Amendment 1
5.5% 1/29/2026
Event 1/22/2026
Caligan Partners LP 13D/A Amendment 1
10.0% 12/30/2025
Event 12/26/2025
Affinity Asset Advisors, LLC 13G
5.5% 12/3/2025
Event 11/25/2025
Paul B Manning 13D/A Amendment 2
49.9% 11/28/2025
Event 11/25/2025
Caligan Partners LP 13D
10.0% 11/24/2025
Event 11/23/2025
Armistice Capital, LLC 13G/A Amendment 3
6.8% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 43 4.66 M $28.5 M
2026 Q1 39 4.78 M $25.3 M
2025 Q4 50 5.20 M $43.2 M
2025 Q3 33 2.47 M $10.6 M
2025 Q2 5 194 k $103 k